Marguglio David J. 4
4 · Adamis Pharmaceuticals Corp · Filed Nov 20, 2019
Insider Transaction Report
Form 4
Marguglio David J.
Director
Transactions
- Sale
Common Stock
2019-11-18$0.87/sh−8,283$7,197→ 365,307 total
Holdings
- 5,884(indirect: By Children)
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in March 2019.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.